Melanoma March physical events in 2022
20 September 2021
We are excited to announce a return to our much-loved physical Melanoma March events next year (COVID restrictions permitting)!
After a two-year hiatus due to COVID, we are looking forward to welcoming back our dedicated community to our physical events across the country.
This will be the 11th year of Melanoma March, and it remains a critical fundraiser to support our national life-saving research under the leadership of Professor Georgina Long AO and Professor Richard Scolyer AO and our many collaborating institutions.
Dates have been set for multiple Melanoma March events and more will be announced in coming months, so please mark the dates in your diary. We can’t wait to welcome you back!
- Western Sydney - 6 March
- Wagga - 13 March
- Manly - 27 March
- Bathurst - date tbc
- Canberra - date tbc
- Melbourne - 20 March
- Bendigo - date tbc
- Brisbane - 13 March
- Rockhampton - date tbc
- Bunbury - 13 March
- Perth - 27 March
- Adelaide - date tbc
- Hobart - 20 March
We'll keep you updated as more locations are added. If you would like to register your interest in participating in an event, and be kept updated via email please go to: melanomamarch.org.au
Together we can take steps to beat melanoma.
Melanoma March is an initiative of Melanoma Institute Australia, incorporating melanomaWA and Amie St Clair. It is proudly supported by Melanoma Patients Australia, Australian Melanoma Research Foundation, Skin Cancer Tasmania and other melanoma research organisations across Australia.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.